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Abstract 
Primary malignant lymphomas in the female genital tract are rare. Most cases are non-
Hodgkin lymphomas of which diffuse large B-cell lymphomas are most commonly seen. 
Symptoms are associated with other, more common diseases; therefore, a doctors’ delay 
can be expected. In this case a woman presented with complaints of urinary obstruction due 
to a large tumour in the pelvic area. A laparotomy was performed. A very large tumour of 
the uterus was found with adherence to the pelvic wall and urinary bladder. Diagnostic 
histological examination showed a diffuse large B-cell lymphoma. Treatment with R-CHOP 
chemotherapy was started shortly after the operation. The treatment of patients with a 
primary malignant lymphoma of the uterus should be individualized with the following 
options: surgery, radiotherapy and/or chemotherapy. 
 
Introduction 
Malignant lymphomas are occasionally found in the uterus or cervix; however, 
primary malignant lymphomas in the female genital tract are rare [1]. The most 
common diagnosis is diffuse large B-cell lymphoma [1, 2]. Main symptoms are 
abnormal vaginal blood loss, abdominal pain and/or urinary obstruction. Most of these 
reported symptoms are associated with more common diseases in gynaecology; as a 
result it takes longer before the correct diagnosis can be made. 
There are few articles available on the optimal approach of this uncommon disease 
[3]. Here, a case report and review of literature are presented for the diagnostic and 
therapeutic options for a patient with a primary malignant lymphoma of the uterus.  
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Case Report 
A 79-year-old woman presented with urinary obstruction in another hospital. Physical 
examination revealed a large pelvic tumour reaching up to the umbilical level. A blind cervical smear 
was taken, showing slight atypical cells. Ultrasonography showed a large pelvic tumour, no distinction 
could be made from uterus, bladder or ovaries. Laboratory data showed an elevated ESR 61 mm/h, 
urea 203 mg/dl, creatinine 5.3 mg/dl, potassium 21.89 mg/dl, and an abnormal haemoglobin level 9.3 
g/dl. Tumour markers (CA-125, AFP, CEA, and B-HCG) were all within the normal range. Magnetic 
resonance imaging (MRI) scan of the abdomen revealed a large pelvic mass, most likely the uterus, 
which compressed the left and right ureter, and bilateral pelvic lymphadenopathy. A cystoscopy was 
performed, showing no signs of tumour invasion in the bladder, and no other abnormalities. An 
attempt to insert double J ureteral stents was unsuccessful. Therefore a bilateral percutaneous 
nephropyelostomy was performed. The patient received potassium supplementation once and two 
packed cells, after which the patient’s clinical condition improved. 
The patient was referred to our hospital. The differential diagnosis included a uterine sarcoma or 
carcinosarcoma. A diagnostic laparotomy was performed. There was a very large tumour from the 
uterus with adherence to the urinary bladder and both pelvic walls. An incisional biopsy was taken 
from the anterior wall of the uterus, which caused a blood loss of 1,000 ml. It was decided to wait for 
the pathological-anatomical results and the abdomen was closed. 
Histological examination showed a diffuse large B-cell lymphoma from the uterus (fig. 1). 
Some days after the operation a tumour was noticed in the patient’s neck, with a diameter of 5 cm. 
A biopsy was performed of this tumour, which showed a localization of the B-cell lymphoma. A bone 
marrow biopsy was taken, which showed normocellular bone marrow. 
A computer tomography (CT) scan of the thorax and abdomen showed an inhomogeneous mass in 
the left hemisphere of the thyroid with retrosternal expansion, multiple pulmonary embolies, and 
besides the known tumour mass of the uterus, a hypodense lesion in the spleen. 
Treatment was started with series of rituximab, cyclophosphamide, adriamycin, vincristine and 
prednisone (R-CHOP) chemotherapy under supervision of the haematology department. After 3 
courses of chemotherapy a clear regression was seen of all tumour localizations and the nephrostomy 
catheters were removed. After 6 courses a control CT scan was performed, which showed regression 
of all intra-abdominal lymphoma localizations; however, the thyroidal localization remained 
somewhat enlarged (fig. 2). A fine needle biopsy was taken, showing normal thyroid tissue, no 
localization of lymphoma cells. Unfortunately, the patient died of cardiac arrest 9 months after 
treatment. 
Discussion 
Primary malignant lymphomas of the uterus or cervix are rare. In most cases of 
lymphomas of the uterus it concerns secondary involvement of the disease [3]. Less 
than 1% of the primary malignant lymphomas occur in the female genitalia [2]. Fox and 
More [4] defined three criteria for primary uterine lymphoma, which are: (1) clinically 
confined to the uterus, (2) no evidence of leukaemia, and (3) a fairly long interval 
between the primary uterine lymphoma and the secondary tumour. Most cases of 
primary uterine lymphoma concern non-Hodgkin lymphoma, usually diffuse large B-
cell lymphoma. Immunohistochemical analysis distinguishes B- from T-cell lymphoma. 
In case of the diagnosis lymphoma, bone marrow biopsy must follow to exclude 
leukaemia [1, 5]. 
Most common symptoms of primary uterine lymphoma are abnormal vaginal blood 
loss or discharge [3, 5] as well as abdominal pain or mass effect as reported in this case. 
PAP smears are usually not abnormal, because primary lymphoma of the cervix or  
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uterus arises in the stroma, and not in the epithelium. Presenting symptoms are not 
characteristic for uterine lymphoma, as they occur in many more diseases; therefore, it 
can take longer to make the right diagnosis [3, 4]. 
In case of radiological examination, MRI is recommended before CT scan as it is 
more discerning in differentiating cervical and uterine lymphomas from other entities 
[3]. 
The prognosis of the patient depends on the stage of the disease, the location and the 
subtype lymphoma. The Ann Arbor classification can be made based on findings on the 
CT scan and bone marrow biopsy [2]. 
Due to low incidence of primary uterine lymphoma large patient series describing 
the optimal treatment method are not available. In the scarce available literature it is 
recommended to treat with hysterectomy and bilateral salpingo-oophorectomy, 
chemotherapy, irradiation or a combination of these [1]. 
R-CHOP chemotherapy was shown to improve 5-year survival rates significantly in 
patients over 60 years of age with diffuse large B-cell lymphoma [6, 7]. No randomized 
controlled trials have been performed on the treatment of primary uterine lymphomas, 
nor are there treatment standards. Therefore it is recommended to individualize the 
treatment for patients with primary lymphomas of the female genital tract [3]. 
Conclusion 
A primary uterine lymphoma is a rare malignancy of the female genital tract. 
Because patients have often nonspecific symptoms, it usually takes longer before the 
correct diagnosis is made. No evidence-based advice is available for treatment due to 
its low incidence; therefore, the treatment of patients with a primary uterine 
lymphoma needs to be individualized. 
 
 
 
 
Fig. 1. Histologic specimen showing diffuse large B-cell lymphoma of the uterus (HE staining). 
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Fig. 2. Above: CT scan showing the primary pelvic mass. Below: CT scan after 6 courses of R-CHOP 
chemotherapy. Regression of the primary tumour is seen. 
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